HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

A single 210-mumol oral dose of retinol does not enhance the immune response in children with measles.

Abstract
This trial assessed the effect of vitamin A on reversing measles-induced unresponsiveness to recall antigens and on enhancing measles antibody production. These assessments were part of a randomized, double-masked clinical trial of the efficacy of 210 mumol of retinol as retinyl palmitate for reducing measles-associated morbidity. Two hundred children between 5 mo and 17 y of age with acute measles were enrolled at the Urban Health Centers in Ndola, Zambia; 110 subjects received a placebo and 90 received vitamin A. At enrollment and 2 wk later, blood samples were collected to determine measles hemagglutinin antibody titer and, at 1 and 2 wk post-enrollment, cutaneous delayed-type hypersensitivity tests (DTH) for seven antigens were applied. Both groups of subjects showed marked DTH unresponsiveness, but vitamin A-treated subjects had a significant prolongation of unresponsiveness to tuberculin [odds ratio (OR) 3.22 and 95% confidence interval (CI) 1.27-8.2], Candida (OR 5.43, CI 1.13-25.9) and Proteus (OR 5.17, CI 1.14-28.4), after adjustment for previous vaccination and age. DTH unresponsiveness was antigen specific, reflecting prior vaccination history, and was not associated with acute respiratory infection status. In addition, children in both treatment groups showed a significant increase in measles antibody titer from baseline to wk 2, but this increment was not significantly different between the groups (P = 0.25). These results indicate that a single oral dose of 210 mumol of retinol as retinyl palmitate in oil does not enhance the immune system during measles.
AuthorsF J Rosales, C Kjolhede
JournalThe Journal of nutrition (J Nutr) Vol. 124 Issue 9 Pg. 1604-14 (Sep 1994) ISSN: 0022-3166 [Print] United States
PMID8089728 (Publication Type: Clinical Trial, Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, Non-P.H.S.)
Chemical References
  • Antibodies, Viral
  • Antigens, Bacterial
  • Antigens, Fungal
  • Hemagglutinins, Viral
  • Vitamin A
Topics
  • Administration, Oral
  • Adolescent
  • Antibodies, Viral (biosynthesis)
  • Antigens, Bacterial (immunology)
  • Antigens, Fungal (immunology)
  • Child
  • Child, Preschool
  • Confidence Intervals
  • Double-Blind Method
  • Female
  • Follow-Up Studies
  • Hemagglutinins, Viral (immunology)
  • Humans
  • Hypersensitivity, Delayed
  • Immunity, Cellular
  • Infant
  • Male
  • Measles (complications, drug therapy, immunology)
  • Measles virus (immunology)
  • Nutrition Disorders (complications)
  • Odds Ratio
  • Pilot Projects
  • Respiratory Tract Infections (complications)
  • Vitamin A (blood, therapeutic use)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: